Investigational cell therapy for severe stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an experimental treatment called RK-4 that is given directly into the bone of the skull shortly after a severe stroke. The goal is to see if it can improve recovery and reduce disability from a major stroke on one side of the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You had a severe stroke affecting a large part of the brain's main blood vessel area.
- You must be able to receive the study treatment within 24 hours of when your stroke symptoms began.
- You must have significant arm and leg weakness due to the stroke.
- If you had a procedure to remove a blood clot, it did not help, and you still meet the trial's criteria.
- You were living independently before the stroke, with no significant disability.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a special solution (RK-4) into the skull can help people with a severe type of stroke caused by a blockage in a major brain artery. The treatment aims to reduce brain damage and improve recovery when given within 24 hours of the stroke.
This trial tests a new way to deliver a medication called RK-4 directly into the skull bone marrow to bypass the blood-brain barrier for people with a major stroke on one side of the brain. The goal is to see if this injection is safe and feasible, and it might help reduce damage after a severe stroke.
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
This trial tests a special emergency stroke unit that uses advanced brain imaging (NeuAngio-CT) to quickly evaluate and treat people having an acute ischemic stroke. It aims to improve outcomes by speeding up care and guiding treatment decisions.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
This study tests a clot-busting medicine given through an IV to people who had a stroke caused by a blocked medium-sized blood vessel in the brain, and who can be treated 4.5 to 24 hours after symptoms start. The goal is to see if it improves recovery and reduces disability compared to standard care.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.